TaesungLtd Balance Sheet Health

Financial Health criteria checks 5/6

TaesungLtd has a total shareholder equity of ₩37.3B and total debt of ₩7.2B, which brings its debt-to-equity ratio to 19.3%. Its total assets and total liabilities are ₩59.5B and ₩22.2B respectively. TaesungLtd's EBIT is ₩3.6B making its interest coverage ratio 19.9. It has cash and short-term investments of ₩8.5B.

Key information

19.3%

Debt to equity ratio

₩7.20b

Debt

Interest coverage ratio19.9x
Cash₩8.48b
Equity₩37.31b
Total liabilities₩22.19b
Total assets₩59.50b

Recent financial health updates

Recent updates

More Unpleasant Surprises Could Be In Store For Taesung Co.,Ltd.'s (KOSDAQ:323280) Shares After Tumbling 32%

Nov 15
More Unpleasant Surprises Could Be In Store For Taesung Co.,Ltd.'s (KOSDAQ:323280) Shares After Tumbling 32%

Be Wary Of TaesungLtd (KOSDAQ:323280) And Its Returns On Capital

Sep 25
Be Wary Of TaesungLtd (KOSDAQ:323280) And Its Returns On Capital

TaesungLtd (KOSDAQ:323280) Seems To Use Debt Quite Sensibly

Jul 23
TaesungLtd (KOSDAQ:323280) Seems To Use Debt Quite Sensibly

TaesungLtd (KOSDAQ:323280) Might Be Having Difficulty Using Its Capital Effectively

May 30
TaesungLtd (KOSDAQ:323280) Might Be Having Difficulty Using Its Capital Effectively

Estimating The Intrinsic Value Of Taesung Co.,Ltd. (KOSDAQ:323280)

Mar 26
Estimating The Intrinsic Value Of Taesung Co.,Ltd. (KOSDAQ:323280)

Financial Position Analysis

Short Term Liabilities: A323280's short term assets (₩29.9B) exceed its short term liabilities (₩21.2B).

Long Term Liabilities: A323280's short term assets (₩29.9B) exceed its long term liabilities (₩999.9M).


Debt to Equity History and Analysis

Debt Level: A323280 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A323280's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: A323280's debt is well covered by operating cash flow (91.8%).

Interest Coverage: A323280's interest payments on its debt are well covered by EBIT (19.9x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/28 00:45
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Taesung Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution